Diversity in Clinical Trials: A Blog Series

Blog
Published on:
March 17, 2023
We are pleased to bring you a new series on “Diversity in Clinical Trials”

It’s universally understood that the biggest problem in clinical research is recruitment and retention — recruiting an adequate number of patients on time and keeping them engaged in the study to completion. But how to successfully engage with patients from diverse populations? To gain the latest insights on the impact, challenges, and strategies, we are pleased to bring you a new series on “Diversity in Clinical Trials” with Jennifer Lannon, Director of Partnerships and Business Development, Patient Advocacy at Alira Health.


Part 1: The Impact of Underrepresentation of Diverse Groups in Clinical Trials

Current data shows that diverse groups continue to be underrepresented in clinical trials. According to FDA data, in 2020, on average 75% of the 32,000 participants in clinical trials for 53 novel drugs were white; only 11% were Hispanic and 8% were Black (while those groups represent 18.9% and 13.6%, respectively, of the population according to US Census data). This is not unusual; historically, the majority of drugs have been tested on white male participants. How does this play out? A lack of diversity during clinical trials has a major impact. | Read Now


Part 2: Challenges to Creating Diversity in Clinical Trials

Now that the FDA has a mandate requiring trial sponsors to include a diversity action plan in their clinical trials, it’s vital that companies comply. This is not only in their business interest but also in the interest of Americans’ health. But what challenges do pharmaceutical and biotech companies face when it comes to representation of diverse groups in clinical trials? | Read Now


Part 3: How Can Clinical Trials be More Inclusive?

How can teams successfully engage with patients from diverse populations? If sponsors engage with these underrepresented groups to create trials that work for them, they can open up access to new trial participants. And given the new law that recently passed (Public Law 117-328), pharmaceutical and biotech companies will soon be required to provide a diversity action plan documenting how they will recruit more diverse populations to their trials. Expanding diversity in trials is not just the right thing to do; it’s now becoming mandatory. | Read Now

Jennifer Lannon Diversity in Clinical Trials

Related news

News March 27, 2023
Alira Health CEO Gabriele Brambilla Interviewed by Investment Reports
Alira Health CEO Gabriele Brambilla recently shared his thoughts on the importance of patient engagement and the digital tools that will allow patients to better manage their own health data and care.
Digital Health Patient Advocacy
News March 27, 2023
Alira Health’s Renee Willmon and MG Registry featured in new Rare Disease Article Series
In the article, “Alira Health and the MGFA Partner to Develop a Myasthenia Gravis Registry,” Renee shares how her professional journey has led her to her current involvement in(...)
Clinical Trials Digital Health Patient Advocacy
Events March 20, 2023
MGFA National Patient Conference 2023
We are pleased to share that we will be participating in MGFA National Patient Conference 2023 as speakers and exhibitors.
Digital Health Innovation Patient Engagement
Blog March 17, 2023
Diversity in Clinical Trials: A Blog Series
How can you successfully engage with patients from diverse populations? To gain the latest insights on the impact, challenges, and strategies, we are pleased to bring you a new series(...)
Clinical Trials Patient Advocacy Patient Engagement
Blog March 16, 2023
How Can Clinical Trials be More Inclusive?
Working with patients and patient leaders early and often can help life science companies to advance the mission of diversifying clinical trials and ultimately, bringing products to(...)
Clinical Trials Patient Advocacy Patient Engagement
Events March 14, 2023
WIRED Health 2023
We are pleased to share that we will be attending and speaking at WIRED Health 2023. WIRED Health highlights the most exciting, thought-provoking disruptors scientists and practitioners(...)
Digital Health Innovation Patient Engagement
Blog March 9, 2023
Challenges to Creating Diversity in Clinical Trials
Now that the FDA has a mandate requiring trial sponsors to include a diversity action plan in their clinical trials, it’s vital that companies comply. What challenges do pharmaceutical(...)
Clinical Trials Patient Advocacy Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.